Atlas Trials

A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

Clinical trial NCT02608697 · COMPLETED

Trial details

NCT number
NCT02608697
Sponsor
Catabasis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2015-10-01
Primary completion
2016-05-01
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.